DiamiR Biosciences Corp., a developer of blood-based diagnostics for brain health, and Aptorum Group Limited (NASDAQ:APM), a ...

Aptorum stock rallied 115.75% in pre-market trading today, following a 3.79% dip yesterday. The shares have decreased 54.56% ...

Aptorum Group shares skyrocketed as New York State Department of Health approved a genotyping test from DiamiR Biosciences, which is merging with Aptorum. The stock more than doubled to $3.37 and is ...

Aptorum stock rises after DiamiR Biosciences secures New York approval for its APOE Genotyping test ahead of a planned merger.

The Axiom Genotyping Solution platform of Affymetrix (AFFX) has been selected by Toshiba's Healthcare Company as the platform for its newly launched genotyping service.

The completion of a massive genotyping on a large and diverse population marks an unprecedented milestone in population-based genetics research and offers a unique and powerful resource to help answer ...

Genotyping tumor tissue in search of somatic genetic alterations for actionable information has become routine practice in clinical oncology. Although these sequence alterations are highly informative ...

Genotyping data sets may contain errors that, in some instances, lead to false conclusions. Deviation from Hardy–Weinberg equilibrium (HWE) in random samples may be indicative of problematic ...

March 16, 2010 (Atlanta, Georgia) — Genotyping warfarin patients resulted in a 30% reduction in all-cause hospitalizations and hospitalizations for bleeds/thromboemboli, a new study suggests ...

A high-throughput genetic screening platform in a single-celled photosynthetic eukaryote would be a transformative addition to the plant biology toolbox. Here, we present ChlaMmeSeq (Chlamydomonas ...